Erythromycin ototoxicity

A call to heighten recognition

Cynthia Whitener, J. E. Parker, N. L. Lapp

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia. Discontinuance of the antibiotic led to prompt correction of the hearing deficit. Reversible hearing loss is an infrequently described adverse effect attributed to high-dose erythromycin therapy. Possible risk factors, including age, gender, and hepatic and renal function, may contribute to the development of erythromycin ototoxicity.

Original languageEnglish (US)
Pages (from-to)1214-1216
Number of pages3
JournalSouthern Medical Journal
Volume84
Issue number10
DOIs
StatePublished - 1991

Fingerprint

Erythromycin
Bilateral Hearing Loss
Pneumococcal Pneumonia
Sensorineural Hearing Loss
Hearing Loss
Hearing
Anti-Bacterial Agents
Kidney
Liver
Therapeutics
erythromycin lactobionate

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Whitener, Cynthia ; Parker, J. E. ; Lapp, N. L. / Erythromycin ototoxicity : A call to heighten recognition. In: Southern Medical Journal. 1991 ; Vol. 84, No. 10. pp. 1214-1216.
@article{813335842de546bf84018b27051758cc,
title = "Erythromycin ototoxicity: A call to heighten recognition",
abstract = "Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia. Discontinuance of the antibiotic led to prompt correction of the hearing deficit. Reversible hearing loss is an infrequently described adverse effect attributed to high-dose erythromycin therapy. Possible risk factors, including age, gender, and hepatic and renal function, may contribute to the development of erythromycin ototoxicity.",
author = "Cynthia Whitener and Parker, {J. E.} and Lapp, {N. L.}",
year = "1991",
doi = "10.1097/00007611-199110000-00013",
language = "English (US)",
volume = "84",
pages = "1214--1216",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

Erythromycin ototoxicity : A call to heighten recognition. / Whitener, Cynthia; Parker, J. E.; Lapp, N. L.

In: Southern Medical Journal, Vol. 84, No. 10, 1991, p. 1214-1216.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Erythromycin ototoxicity

T2 - A call to heighten recognition

AU - Whitener, Cynthia

AU - Parker, J. E.

AU - Lapp, N. L.

PY - 1991

Y1 - 1991

N2 - Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia. Discontinuance of the antibiotic led to prompt correction of the hearing deficit. Reversible hearing loss is an infrequently described adverse effect attributed to high-dose erythromycin therapy. Possible risk factors, including age, gender, and hepatic and renal function, may contribute to the development of erythromycin ototoxicity.

AB - Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia. Discontinuance of the antibiotic led to prompt correction of the hearing deficit. Reversible hearing loss is an infrequently described adverse effect attributed to high-dose erythromycin therapy. Possible risk factors, including age, gender, and hepatic and renal function, may contribute to the development of erythromycin ototoxicity.

UR - http://www.scopus.com/inward/record.url?scp=0026068078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026068078&partnerID=8YFLogxK

U2 - 10.1097/00007611-199110000-00013

DO - 10.1097/00007611-199110000-00013

M3 - Article

VL - 84

SP - 1214

EP - 1216

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 10

ER -